Novartis Ag (NVS) Change in Cash (2009 - 2026)

Novartis Ag has disclosed Change in Cash across 18 years of filings, most recently posting $739.0 million for Q2 2026.

• In Q2 2026, Change in Cash rose 280.24% year-over-year to $739.0 million; the TTM figure through Jun 2026 stood at -$2.4 billion (down 117.45% YoY), while the FY2025 annual figure was $17.6 billion, up 8.26% from the prior year.
• Change in Cash came in at $739.0 million for Q2 2026 at Novartis Ag, up from -$4.6 billion in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $12.6 billion in Q4 2024 to a low of -$10.2 billion in Q2 2022.
• Average Change in Cash over 5 years is $381.7 million, with a median of $164.5 million recorded in 2025.
• Year-over-year, Change in Cash tumbled 877.13% in 2022 and surged 1177.13% in 2024.
• Over 5 years, Change in Cash stood at -$1.2 billion in 2022, then soared by 181.72% to $988.0 million in 2023, then surged by 1177.13% to $12.6 billion in 2024, then sank by 138.06% to -$4.8 billion in 2025, then surged by 115.39% to $739.0 million in 2026.
• Per Business Quant data, the three most recent Change in Cash figures were $739.0 million in Q2 2026, -$4.6 billion in Q1 2026, and -$4.8 billion in Q4 2025.